05:33 PM EST, 02/19/2026 (MT Newswires) -- Mark Elliott Boulding, Executive Vice President, Chief Legal Officer, on February 17, 2026, sold 5,894 shares in PTC Therapeutics ( PTCT ) for $408,613. Following the Form 4 filing with the SEC, Boulding has control over a total of 108,231 common shares of the company, with 108,231 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1070081/000157885226000008/xslF345X05/form4-02192026_050201.xml